Cancer Antigen 125: Lost to Follow-Up? A European Society of Gynaecological Oncology Consensus Statement
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F12%3A13101" target="_blank" >RIV/00216208:11110/12:13101 - isvavai.cz</a>
Alternative codes found
RIV/00064165:_____/12:13101
Result on the web
<a href="http://dx.doi.org/10.1097/IGC.0b013e318226c636" target="_blank" >http://dx.doi.org/10.1097/IGC.0b013e318226c636</a>
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Cancer Antigen 125: Lost to Follow-Up? A European Society of Gynaecological Oncology Consensus Statement
Original language description
A recent study on the use of cancer antigen 125 (CA-125) in follow-up of patients with epithelial ovarian cancer after complete response on primary treatment is critically reviewed. As it has been suggested to refrain from CA-125 altogether, this European Society of Gynaecologic Oncology report has also reviewed possible disadvantages, even possible harm, and potentially missed opportunities when such policy would be implemented. It is concluded that indeed routine use of CA-125 does not provide patientbenefit in survival or quality of life. However, there may be other reasons for monitoring CA-125, which are discussed in this review. It is noted that the lack of benefit of CA-125 monitoring has only been proven for a specific subset of ovarian cancerpatients with serous histology and frequent follow-up visits including imaging and in a clinical environment where, particularly, surgery for recurrent disease and clinical studies on new second-line agents will not be considered. A spec
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FK - Gynaecology and obstetrics
OECD FORD branch
—
Result continuities
Project
—
Continuities
N - Vyzkumna aktivita podporovana z neverejnych zdroju
Others
Publication year
2012
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
International Journal of Gynecological Cancer
ISSN
1048-891X
e-ISSN
—
Volume of the periodical
22
Issue of the periodical within the volume
1
Country of publishing house
US - UNITED STATES
Number of pages
5
Pages from-to
170-174
UT code for WoS article
000298628800028
EID of the result in the Scopus database
—